Literature DB >> 1671219

Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole.

C Azuma1, F Saji, Y Tokugawa, T Kimura, T Nobunaga, M Takemura, T Kameda, O Tanizawa.   

Abstract

To investigate the pathogenesis of complete hydatidiform mole (complete mole), we employed a newly developed gene amplification method by polymerase chain reaction (PCR) for the restriction fragment length polymorphism (RFLPs) analysis of extranuclear DNA (mitochondrial DNA) of complete mole. Whole cellular DNA was extracted from six molar tissues and from peripheral blood mononuclear cells of parents. Two hyperpolymorphic regions of mitochondrial DNA, a 1.5-kb-long fragment and a 1.9-kb-long fragment, were selectively amplified from the extracted DNA by the PCR method. The amplification products amounted to over 10 micrograms after 30 cycles of PCR. The PCR products were digested with endonucleases (HaeIII, HinfI, AluI, and TaqI) and then electrophoresed on agarose gel. The electrophoretic pattern of digested DNA showed that the RFLPs of molar mitochondrial DNA coincided with those of the patient, indicating that the mitochondrial DNA of complete mole was inherited from the ovum. As it has been identified that the intranuclear DNA of complete mole is transmitted only from the spermatozoa, our results verify that complete mole results from the fertilization of an anuclear "empty" ovum with normal sperm at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671219     DOI: 10.1016/0090-8258(91)90080-o

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Prevalence of gestational trophoblastic disease in ectopic pregnancy.

Authors:  Ilir Tasha; Enriketa Kroi; Anila Karameta; Rozeta Shahinaj; Nikita Manoku
Journal:  J Prenat Med       Date:  2010-04

2.  Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.

Authors:  Xing-Zheng Zheng; Xu-Ying Qin; Su-Wen Chen; Peng Wang; Yang Zhan; Ping-Ping Zhong; Natalia Buza; Yu-Lan Jin; Bing-Quan Wu; Pei Hui
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

3.  BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression.

Authors:  Revathy Nadhan; Jayashree Vijaya Vaman; Satheesh Kumar Sengodan; Sreelatha Krishnakumar Hemalatha; Nirmala Chellappan; Santha Sadasivan; Aysha Pasuthottiyil Varkey; Sreelekha Yesodharan; Krishnapriya Raji Sathyanpillai; Amritha Krishna Bhuvaneswari Venugopal; Sreevidya Prameelakumari Sreenivasan; Arathi Rajan; Neetha Rajan Latha; Geetu Rose Varghese; Ratheeshkumar Thankappan; Sarada Achyutuni; Jithin Dev Sreekumar Usha; Thapasimuthu Vijayamma Anilkumar; Priya Srinivas
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

Review 4.  Gestational Trophoblastic Disorders: An Update in 2015.

Authors:  F T Stevens; N Katzorke; C Tempfer; U Kreimer; G I Bizjak; M C Fleisch; T N Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

Review 5.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

6.  Identification of Metabolic Biomarkers Using Serial 18F-FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian Cancer.

Authors:  Tae Hun Kim; Junhwan Kim; Yeon-Koo Kang; Maria Lee; Hee Seung Kim; Gi Jeong Cheon; Hyun Hoon Chung
Journal:  Transl Oncol       Date:  2017-03-15       Impact factor: 4.243

7.  A 34-Week Size Uterus with a Complete Hydatidiform Mole: Hook Effect and Severe Anemia with No Vaginal Bleeding.

Authors:  Rodney McLaren; Vijaya Bayya; Mohamad Irani
Journal:  Case Rep Obstet Gynecol       Date:  2018-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.